US 10815285
Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases
granted A61KA61K38/00A61K48/00
Quick answer
US patent 10815285 (Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases) held by United States Government as represented by the Department of Veterans Affairs expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/00, A61K48/00